# Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

> **NCT05245227** · PHASE3 · RECRUITING · sponsor: **Stony Brook University** · enrollment: 1358 (estimated)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Sublingual Misoprostol
- **DRUG:** IV Oxytocin

## Key facts

- **NCT ID:** NCT05245227
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-27
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 1358 (ESTIMATED)
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05245227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05245227, "Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05245227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*